Innovations are good thing if we use it to achieve better health outcomes. Last class I learn that the agency in charge of the regulations will not focus in the economic aspect of the new technology just in the efficacy and the security of the new innovations. But up to what extend the raising in the health cost that we are experience is because of excessive use of expensive technologies. I can imagine that there is a link between those.
One possible suggestion is that they made recommendations for the use of the new technologies.
For example the American Academy of pediatrics does this and for the consumer is very useful. Sometimes decide without advice could be very difficult, specially when something so important as health is involved.And as public health professionals we wont people to be informed by neutrals players as much as possible, if they do not made recommendations there will be others that will take this role,with the potential risk of having economic interests involved.
Subscribe to:
Post Comments (Atom)
1 comment:
marina, i agree with you that the economic aspect should be considered when exploring new drug possibilities. it's very telling about our nation's priorities that we don't consider it, while other countries do.
Post a Comment